COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year End Financials May 1st
23/04/2019
Pure Sunfarms on track to reach annual production run-rate of 75,000 kilograms by mid-2019 Company to host 2018 fourth quarter and year end financial results conference call Wednesday, May 1, 2019 at 8:30 a.m. ET [...]
Aleafia Health Added to NYSE-Listed AdvisorShares Pure Cannabis ETF
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) has been added to the AdvisorShares Pure Cannabis ETF (NYSE: YOLO) (“ YOLO ”), [...]
Orphazyme’s Phase II/III trial in sporadic Inclusion Body Myositis fully enrolled
23/04/2019
Orphazyme A/S Company announcement No. 13/2019 Company Registration No. 32266355 Study completion expected by end 2020 Results expected in H1 2021 Copenhagen, April 23, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a [...]
BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston
23/04/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, April 23, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem® Treatment for Acute Respiratory Distress Syndrome
23/04/2019
Off-the-shelf stem cell therapy has potential to enhance recovery for ARDS patients CLEVELAND, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (“ [...]
Share buy-back week 16/2019
23/04/2019
Announcement 23 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Les personnes souffrant d’obésité sont discriminées
23/04/2019
OTTAWA, 23 avr. 2019 (GLOBE NEWSWIRE) -- Le second bulletin d’Obésité Canada qui évalue l’accès au traitement conclut que les Canadiens affectés par l’obésité continuent d’être ignorés par les systèmes de santé, par les [...]
Canadians with Obesity Treated as Second-Class Citizens Compared with Other Chronic Diseases: Report
23/04/2019
OTTAWA, April 23, 2019 (GLOBE NEWSWIRE) -- Obesity Canada’s second report card assessing access to treatment concludes Canadians living with obesity continue to be ignored by healthcare systems and health policy makers [...]
MJBizDaily Introduces MJBizDaily European Cannabis Symposium, Copenhagen, Denmark, May 6
23/04/2019
DENVER, April 23, 2019 (GLOBE NEWSWIRE) -- The producers of America’s oldest and largest cannabis trade show, Marijuana Business Conference & Expo (MJBizCon) , introduce MJBizDaily’s European Cannabis Symposium in [...]
Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin Trial in Breast Cancer-Associated Lymphedema
23/04/2019
Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin ® Trial in Breast Cancer-Associated Lymphedema Herantis Pharma Plc Company release 23 April 2019 at 9:00 am Herantis Pharma Plc (“Herantis”) [...]
Biocartis Group NV: Biocartis Announces Global Collaboration with Covance
23/04/2019
PRESS RELEASE : 23 April 2019, 07:00 CEST Biocartis Announces Global Collaboration with Covance Mechelen, Belgium, 23 April 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics [...]
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 23 May 2019 have been made available
23/04/2019
Regulated information Gosselies, Belgium, 23 April 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 23 mai 2019
23/04/2019
Information réglementée Gosselies, Belgique, le 23 avril 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the United States
23/04/2019
SHANGHAI, China, April 22, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (HKEX: 2552), a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the treatment of Type 2 diabetes, [...]
Extendicare Announces Nomination of Two New Directors and Agreement with Sandpiper Group
23/04/2019
MARKHAM, Ontario, April 22, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announces that it has entered into an agreement (the “Agreement”) with Sandpiper Group, which holds 9% of [...]
National Research Corporation to Broadcast its 2019 First Quarter Conference Call Live on the Internet
22/04/2019
Lincoln, Nebraska, April 22, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2019 first quarter earnings conference call on [...]
Chembio Diagnostics to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
MEDFORD, N.Y., April 22, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Eve & Co Announces Board Appointment of Alice Murphy
22/04/2019
TORONTO, April 22, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that Alice Murphy has been appointed to its Board of Directors. [...]
Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development
22/04/2019
SAN FRANCISCO, April 22, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]

Pages